Perfusion of 99Tcm-labeled CD105 Mab into kidneys from patients with renal carcinoma suggests that CD105 is a promising vascular target.
D000911:Antibodies, Monoclonal / Q000493:pharmacokinetics; D015703:Antigens, CD; D002292:Carcinoma, Renal Cell / Q000098:blood supply*; D000071063:Endoglin; D004730:Endothelium, Vascular; D006801:Humans; D007680:Kidney Neoplasms / Q000098:blood supply*; D009389:Neovascularization, Pathologic / Q000000981:diagnostic imaging* / Q000378:metabolism; D010477:Perfusion; D016719:Radioimmunodetection; D011956:Receptors, Cell Surface; D013667:Technetium / Q000493:pharmacokinetics; D019010:Vascular Cell Adhesion Molecule-1 / Q000276:immunology*
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; C064206:ENG protein, human; D000071063:Endoglin; D011956:Receptors, Cell Surface; D019010:Vascular Cell Adhesion Molecule-1; D013667:Technetium